Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Carl A, Laskin"'
Autor:
Natalie Dayan, Gabriel D. Shapiro, Jin Luo, Jun Guan, Deshayne B. Fell, Carl A. Laskin, Olga Basso, Alison L. Park, Joel G. Ray
Publikováno v:
BMC Pregnancy and Childbirth, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Improvement in the prediction and prevention of severe maternal morbidity (SMM) - a range of life-threatening conditions during pregnancy, at delivery or within 42 days postpartum - is a public health priority. Reduction of SMM at
Externí odkaz:
https://doaj.org/article/6e51170ff66c4437af78c78543e97f40
Autor:
Julia Davis-Porada, Mimi Y. Kim, Marta M. Guerra, Carl A. Laskin, Michelle Petri, Michael D. Lockshin, Lisa R. Sammaritano, D. Ware Branch, Allen Sawitzke, Joan T. Merrill, Jill P. Buyon, Jane E. Salmon
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-8 (2020)
Abstract Background Lupus patients are at risk for pregnancy loss, and it has been generally accepted that women with SLE should have low disease activity prior to conception. However, there are conflicting results regarding the effect of pregnancy o
Externí odkaz:
https://doaj.org/article/300210428d164ca5b36b01e0553d3906
Autor:
Geneviève Genest, Shorooq Banjar, Walaa Almasri, Coralie Beauchamp, Joanne Benoit, William Buckett, Frederick Dzineku, Phil Gold, Michael H Dahan, Wael Jamal, Isaac Jacques Kadoch, Einav Kadour-Peero, Louise Lapensée, Pierre Miron, Talya Shaulov, Camille Sylvestre, Togas Tulandi, Bruce D Mazer, Carl A Laskin, Neal Mahutte
Publikováno v:
Reproduction. 165:R39-R60
In brief Immune dysfunction may contribute to or cause recurrent implantation failure. This article summarizes normal and pathologic immune responses at implantation and critically appraises currently used immunomodulatory therapies. Abstract Recurre
Autor:
Julie Barsalou, Edgar Jaeggi, Lars Grosse-Wortmann, Carl A Laskin, Khosrow Adeli, Earl D Silverman
Publikováno v:
Rheumatology.
ObjectivesCardiac involvement in neonatal lupus erythematosis (NLE) can present as myocarditis/endocardial fibroelastosis (EFE). It is unknown whether high-sensitivity cardiac troponin T (hs-cTnT) is useful in identifying subclinical myocardial infla
Autor:
Pierre Miron, Togas Tulandi, Isaac Jacques Kadoch, Michael H. Dahan, William Buckett, Carl A. Laskin, Louise Lapensée, Camille Sylvestre, Walaa Almasri, Frederick Dzineku, Phil Gold, Shorooq Banjar, Coralie Beauchamp, Wael Jamal, Neal G Mahutte, Ciriaco A. Piccirillo, E. Demirtas, Geneviève Genest
Publikováno v:
F&S Reviews. 3:24-41
Recurrent pregnancy loss (RPL) is frequently encountered in the outpatient setting. Despite extensive investigation, up to 50% of patients will be diagnosed with idiopathic RPL, for which no effective treatment exists. While the immune system is intr
Autor:
Genevieve, Genest, Shorooq, Banjar, Walaa, Almasry, Coralie, Beauchamp, Joanne, Benoit, William, Buckett, Frederick, Dzineku, Phil, Gold, Michael Haim, Dahan, Wael, Jamal, Isaac Jacques, Kadoch, Einav, Kadour-Peero, Louise, Lapensée, Pierre, Miron, Talya, Shaulov, Camille, Sylvestre, Togas, Tulandi, Bruce D, Mazer, Carl A, Laskin, Neal, Mahutte
Publikováno v:
Reproduction (Cambridge, England).
Recurrent implantation failure (RIF) may be defined as the absence of pregnancy despite the transfer of ≥ 3 good quality blastocysts and is unexplained in up to 50% of cases. There are currently no effective treatments for patients with unexplained
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162509 (2016)
Circulating Anti-Müllerian hormone (AMH) is derived from the gonads, and is a mixture of the prohormone (proAMH), which does not bind to AMH receptors, and receptor-competent AMH. The functions of a hormone are partially defined by the factors that
Externí odkaz:
https://doaj.org/article/ba1c0d70801c42c3ad730baf9eacac50
Autor:
Karen A. Spitzer, Angel Petropanagos, Robert F. Casper, Carl A. Laskin, Kenneth Cadesky, Shawn Winsor, Kari Ala-Leppilampi, Dara Roth Edney
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 42:568-575
Objective On December 21, 2015, the Province of Ontario created the Ontario Fertility Program to fund one cycle of in vitro fertilization (IVF) to improve IVF affordability and access for Ontarians below age 43. The objective of this study was to det
Autor:
Emily C. Somers, Arundathi Jayatilleke, Nancy Sullivan, Marat Turgunbaev, Laura Tarter, D. Ware Branch, Amy S. Turner, Arthur Kavanaugh, Lauren A. Plante, Julia F. Simard, Christina D. Chambers, Lisa Christopher-Stine, Brittany Bettendorf, Jill P. Buyon, Evelyne Vinet, Amit Aakash Shah, Lisa R. Sammaritano, Sara K. Tedeschi, Bonnie L. Bermas, Gordon H. Guyatt, John J. Cush, Maurice L. Druzin, C. Whitney White, E. Chakravarty, Mehret Birru Talabi, Megan E.B. Clowse, Jane E. Salmon, Michael D. Lockshin, Medha Barbhaiya, Jinoos Yazdany, Kristen E. D'Anci, Virginia D. Steen, Amanda M Eudy, Wendy Marder, Rachelle Crow‐Hercher, Carl A. Laskin
Publikováno v:
Arthritis & Rheumatology. 72:529-556
Objective To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement therapy (HRT), pregnancy assessment and management, an